Laboratory and human studies suggest that folate intake may influence the risk of some cancers. However, prospective information about the relation between folate intake and the risk of exocrine pancreatic cancer is limited. The authors examined the relation of dietary folate intake to the risk of pancreatic cancer in two large prospective US cohorts. Folate intake was assessed by food frequency questionnaire in 1984 in women and in 1986 in men. Multivariate relative risks were adjusted for age, energy intake, cigarette smoking, body mass index, diabetes, and height. During 14 years' follow-up in each cohort, 326 incident cases of pancreatic cancer were identified. Compared with participants in the lowest category of folate intake, participants in increasing 100-µg categories of total energy-adjusted folate intake had pooled multivariate relative risks for pancreatic cancer of 1.08, 1.10, and 1.03 (95% confidence interval: 0.74, 1.43; p trend = 0.99). For energy-adjusted folate from food, the pooled relative risks for increasing 100-µg categories of intake were 0.81, 0.89, and 0.66 (95% confidence interval: 0.42, 1.03; p trend = 0.12). There was no statistical interaction between folate intake and methionine, alcohol, fat, or caffeine. The results from these two large prospective cohorts do not support a strong association between energy-adjusted folate intake and the risk of pancreatic cancer.
uracil into DNA leading to chromosomal instability (5) (6) (7) (8) . Additionally, methyl-group availability from folate may influence the risk of cancer through global hypomethylation of DNA, leading to genomic instability and increased mutation rates (9, 10) , or through hypermethylation of tumor suppressor genes. Pancreatic tumors exhibit a number of molecular-genetic alterations (11) (12) (13) and aberrant patterns of gene methylation (14, 15) . Thus, variability in the availability of folate-derived methyl groups may plausibly influence the risk of pancreatic cancer through altered cellular capacity for mutation or epigenetic methylation.
In previous epidemiologic studies, increased folate consumption has been associated with a decreased risk of colon cancer in men (16) and in women (17) and among women with a positive family history of colon cancer in particular (18) . Furthermore, among women who consume 15 or more g of alcohol per day, breast cancer risk appears to be lower among those with higher folate consumption (19) and plasma folate levels (20) . In a case-control analysis nested within a cohort of male Finnish smokers, compared with those in the bottom tertile of serum folate, participants in increasing tertiles of serum folate had odds ratios for pancreatic cancer of 0.74 and 0.45 (21) . Moreover, in a longitudinal analysis of the same cohort, higher dietary folate intake was associated with a lower risk of pancreatic cancer (22) . In other case-control studies, both an inverse association between folate intake and pancreatic cancer (23) and no association have been observed (24) .
The authors examined the relation of dietary folate to the risk of pancreatic cancer in two large prospective cohorts of women and men with detailed dietary information and up to 14 years of follow-up, the Nurses' Health Study and the Health Professionals Follow-up Study.
MATERIALS AND METHODS

Description of the cohorts
The Nurses' Health Study is an ongoing cohort study established in 1976, with 121,701 responses to a mailed questionnaire from married registered nurses in the United States who were aged 30-55 years. Detailed information on individual characteristics and behaviors was obtained from questionnaires at baseline and biennially thereafter. Dietary information was first assessed in the Nurses' Health Study in 1980 (25, 26) . However, to maximize consistency with the Health Professionals Follow-up Study cohort, these analyses use the more detailed 1984 food frequency questionnaire, the baseline dietary measure. After exclusions for cancer prior to 1984 (except nonmelanoma skin cancer) and missing dietary information, 77,640 women were eligible for analysis at the 1984 baseline.
The Health Professionals Follow-up Study began in 1986 with 51,529 responses from male health professionals to a mailed questionnaire. The participants are US dentists, veterinarians, pharmacists, optometrists, osteopathic physicians, and podiatrists who were between the ages of 40 and 75 years at the beginning of the study. Detailed information on individual characteristics and behaviors was obtained from the questionnaires at baseline and biennially thereafter.
After exclusions for cancer prior to 1986 (except nonmelanoma skin cancer) and missing dietary information, 47,840 men were eligible for analysis in 1986.
Dietary assessment
Baseline diet was assessed in 1984 for the Nurses' Health Study and in 1986 for the Health Professionals Follow-up Study using a 131-item semiquantitative food frequency questionnaire, described in detail elsewhere (27, 28) . Participants were presented with a list of foods, each with a commonly used portion or serving size. Participants were asked how often, on average, they had consumed the specified amount of each food, with nine categories from which to choose. The questionnaire also asked for information on the brand of multivitamin typically used, as well as the brand and type of breakfast cereal used. Participants who were current multivitamin users were asked to state how many years they had been taking multivitamins. Nutrient intakes were computed by multiplying the consumption frequency of each unit of every food by the nutrient content of the portion specified. Values for the nutrient amounts in foods were obtained from the Harvard University Food Composition Database, derived from US Department of Agriculture sources (29) . All nutrient values were adjusted for total energy intake by the residuals method (30) . The validity of the nutrient consumption measured by the food frequency questionnaires was evaluated in subsamples of cohort participants residing in the Boston, Massachusetts, area who completed detailed 1-week diet records (27, 31) . The Pearson correlation coefficient between the questionnaire estimates and the dietary record estimates of total energyadjusted folate was r = 0.73. Furthermore, in the Health Professionals Follow-up Study of diet record validation, the correlation between folate calculated from the semiquantitative food frequency questionnaire and red cell folate level was 0.56 (32) . Among women in the 1986 Nurses' Health Study of diet validation, the correlation between folate calculated from the semiquantitative food frequency questionnaire and red cell folate level was 0.55 (33) . The mean erythrocyte folate levels of the mean by quintile of total folate intake from lowest to highest quintile were 301 (standard error (SE), 15), 341 (SE, 10), 355 (SE, 11), 355 (SE, 11), and 406 (SE, 21) ng/ml, respectively. The reproducibility and validity of self-reported alcohol consumption were assessed in both cohorts by comparing the responses of four 1-week dietary records with the answers provided on the semiquantitative food frequency questionnaire (34) . The correlation between the two measures was high (Spearman's r = 0.90 in women and 0.86 in men).
Pancreatic cancer case and death ascertainment
In both cohorts, participants were asked to report specific medical conditions including cancers that had been diagnosed in the 2-year period prior to each follow-up questionnaire. Whenever a participant (or next of kin for decedents) reported a diagnosis of pancreatic cancer, permission was sought to obtain related medical records, including pathology reports. If permission to obtain records was denied, an attempt was made to confirm the self-reported cancer with an additional letter or telephone call to the participant. If the primary cause of death listed on a death certificate was a previously unreported pancreatic cancer case, a family member was contacted (subject to state regulations) to obtain permission to retrieve medical records or at least to confirm the diagnosis of pancreatic cancer. Most deaths in these cohorts were reported by family members or by the postal service in response to the follow-up questionnaires. Additionally, searches of the National Death Index for nonrespondents were conducted, resulting in a sensitivity of about 98 percent in identifying decedents (35) . We were able to obtain pathology reports confirming the diagnosis of pancreatic cancer for greater than 90 percent of cases. For the remaining cases, we obtained confirmation of the selfreported cancer from a secondary source (e.g., death certificate, physician, or telephone interview of a family member). All medical records had complete information on cytohistology (hospitals were recontacted if the original information sent was incomplete). All associations were initially examined both including and excluding cases with missing records. Because no material differences were observed between these two types of cases, we included those cases without medical records in the final analyses. Following the exclusion of participants with prior cancers or missing dietary information, 139 confirmed incident pancreatic cancer cases were diagnosed between 1984 and 1998 among the women of the Nurses' Health Study, and 187 cases were diagnosed between 1986 and 2000 among the men of the Health Professionals Follow-up Study.
Statistical analyses
We computed person-time of follow-up for each participant from the return date of the baseline questionnaire to the date of pancreatic cancer diagnosis, death from any cause, or the end of follow-up, whichever came first. Incidence rates of pancreatic cancer were computed by dividing the number of incident cases by the number of person-years in each category of exposure. We computed the relative risk for each of the upper exposure categories by dividing the incidence rate in each category by the rate in the lowest category.
Relative risks adjusted for potential confounders were approximated by Cox proportional hazards regression (36) . SAS/STAT PROC PHREG software (SAS Institute, Inc., Cary, North Carolina) was used for proportional hazards regression analysis, and the Anderson-Gill data structure was used to adjust for time-varying covariates efficiently (37) . A new data record is created for every questionnaire cycle at which a participant was at risk, with covariates set to their values at the time that the questionnaire was returned. To control for confounding by age, calendar time, and any possible two-way interactions between these two time scales, we stratified the analysis jointly by age in 5-year categories at the start of follow-up and by calendar year of the current questionnaire cycle. For multivariate analyses, height was categorized into quintiles. Cigarette smoking status was categorized as current, former, or never smokers and updated biennially. In multivariable models, we controlled for the presence or absence of a history of diabetes, updating biennially (38, 39) . On the basis of previous analyses of these cohorts (40) , participants were categorized into five groups of baseline body mass index using whole number cutpoints including widely used definitions of overweight and obesity (38, 41) . Body mass index was not updated in the analysis because pancreatic cancer is frequently associated with profound weight loss, and previous findings in these cohorts showed the strongest associations for baseline body mass index (40) . Information on physical activity was first assessed in detail in 1986 in both cohorts. On the basis of previous analyses, total vigorous and nonvigorous activity was divided into categories of metabolic equivalent tasks (40) . Glycemic load, glycemic index, and physical activity were excluded from multivariate models because they were not confounders in these analyses. Moreover, the intakes of total fats, beta-carotene, and caffeine did not confound or modify the relation between folate intake and pancreatic cancer. We present multivariate models adjusted for age and the covariates previously identified to have the strongest associations with pancreatic cancer in these cohorts: body mass index, height, cigarette smoking, and diabetes.
We used questionnaire responses to determine the duration of use of multivitamin supplements at baseline in both cohorts. For the Nurses' Health Study, the duration of multivitamin use was asked in the prebaseline 1980 questionnaire. Therefore, to compute a 1984 baseline value of multivitamin supplement use, we used the value given on the 1980 questionnaire and added 4 years of duration for women who reported current use in both 1980 and 1984 or carried the 1980 value forward for women who reported no current multivitamin supplement use in 1984. For the Health Professionals Follow-up Study, the response to the 1986 baseline question on the duration of multivitamin use was used. Before 1973, the maximum dose allowed in supplements by the US Food and Drug Administration was 100 µg, and many supplement formulations did not contain folic acid (42) . Thus, the authors considered 1973 (when doses of 400 µg were first allowed) to be the earliest possible starting point.
Statistical interaction was assessed by likelihood ratio tests, comparing full models, including interaction terms, with reduced models without interaction terms. Tests for linear trend were performed using the median value of the independent variable for each category. We pooled the data from the two cohorts using a random-effects model for the log of the relative risks (43) . Tests of heterogeneity using the Q statistic were performed before pooling (43) . The proportionality of hazards was tested by likelihood ratio tests comparing saturated models having age-by-variable interactions with constrained models without interaction terms. The models presented all satisfy the proportionality of hazards assumption. All statistical procedures were performed using SAS version 8.2 software (SAS Institute, Inc.). All p values are based on two-sided tests.
RESULTS
Baseline characteristics of women in the Nurses' Health Study and of men in the Health Professionals Follow-up
Study categorized by total energy-adjusted folate intake are shown in table 1. The relations between folate intake and age-standardized covariates were similar in men and women. Those with the lowest folate intake tended to be younger, to smoke cigarettes, and to have higher alcohol consumption than those with higher folate consumption. Height, body mass index, history of diabetes, and methionine intake were not appreciably different across categories of folate intake.
Total energy-adjusted folate intake was not associated with the risk of pancreatic cancer in either men or women (table 2) . Compared with the risk for men who consumed less than 300 µg of folate per day, the multivariate-adjusted relative risks of pancreatic cancer for men having increasing 100-µg categories of total energy-adjusted folate intake were 1.07, 1.14, and 0.98 (95 percent confidence interval (CI): 0.65, 1.46; p trend = 0.73). Among women, compared with the risk for those who had a daily intake of less than 200 µg of total folate, the relative risks of pancreatic cancer for increasing 100-µg categories of total energy-adjusted folate were 1.10, 1.03, and 1.15 (95 percent CI: 0.65, 2.04; p trend = 0.65). Furthermore, in pooled results from both cohorts, there was no discernable trend in risk of pancreatic cancer with increasing consumption of total energy-adjusted folate. Compared with the risk of the lowest category, multivariateadjusted relative risks for increasing categories of total folate intake were 1.08, 1.10, and 1.03 (95 percent CI: 0.74, 1.43; p trend = 0.99).
Because multivitamin supplement use contributed 25 percent of total folate intake in these cohorts, we examined the relation of folate intake from supplements (i.e., nonfood In a previous analysis of these cohorts, alcohol intake was not associated with pancreatic cancer risk (40) . However, because alcohol can impair folate status as well as antagonize methylation pathways, alcohol consumption could modify the relation of folate intake to cancer risk (44) . We therefore assessed the influence of folate intake according to alcohol consumption. Because statistical power was limited, alcohol intake was categorized as greater than or equal to or as less than 10 g per day for men and as greater than or equal to or as less than 5 g per day for women. There was no significant inverse association between folate intake and pancreatic cancer risk within either stratum of alcohol consumption. Moreover, tests for statistical interaction between folate and alcohol intake were not significant in either cohort.
As an important methyl-group donor, methionine may modify the effect of folate consumption on the risk of pancreatic cancer (45) . In particular, low levels of methionine may increase the need for folate-supplied methyl groups (33) . The pooled multivariate relative risks for (table 2) . Furthermore, after stratification according to low (quintiles 1 and 2) or high (quintiles 3-5) methionine intake, total folate intake was not associated with pancreatic cancer, and tests for statistical interaction between folate and methionine intake were not significant in either cohort. Cigarette smoking impairs folate metabolism (46) and may interact with folate in association with pancreatic cancer risk. We therefore repeated analyses after stratifying the cohort according to cigarette smoking status. There was no significant heterogeneity of associations between folate intake and pancreatic cancer risk in either cohort when stratified by categories of cigarette smoking. In a comparison with results from the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) cohort, those from analyses restricted to currently smoking males yielded 33 cases in 60,775 person-years of follow-up. Among currently smoking men, compared with risk for less than 300 µg of intake, the age-adjusted relative risks for increasing 100-µg categories of food-folate intake were 0.81, 0.71, and 0.83 (95 percent CI: 0.19, 3.62). Relative risks for analogously increasing 100-µg categories of folate from supplements were 4.03, 1.90, and 1.73 (95 percent CI: 0.51, 5.83). Data for smokers were notably sparse, and estimates of associations between folate intake and pancreatic cancer were imprecise.
DISCUSSION
In this prospective analysis of two large cohorts, total energy-adjusted folate intake was not associated with the risk of pancreatic cancer. Results were similar for men and women, and the findings remained unchanged after stratification by alcohol or methionine intake or by smoking status.
Few studies have examined the relation between folate intake and the risk of pancreatic cancer, and the results have been conflicting (21) (22) (23) (24) . In 27,101 male Finnish smokers, a significant inverse relation between dietary folate and pancreatic cancer risk (22) was seen. However, in a nested substudy of plasma folate in this cohort, 90 percent of participants had less than adequate levels, and 25 percent would be considered deficient (21) . When examining the relative risks across quintiles of folate intake in the Finnish cohort, we found that the principal result was an elevated risk within the lowest quintile of intake rather than a monotonic relation with increasing intake (relative risks for each quintile = 1.00, 0.67, 0.59, 0.89, 0.52). Thus, a demonstrable influence of folate consumption may be restricted to populations that are relatively folate deficient.
Although we found no influence of supplemental folate or total folate (from food and supplements combined), we did observe a nonsignificant inverse trend for folate from food sources in both cohorts. For comparison, fewer than 6 percent of participants in the Finnish cohort used folatecontaining supplements, and the apparent effect of folate in those studies was reflective of food sources only and therefore most similar to our analysis of food-folate intake. Moreover, participants in the Finnish cohort who reported supplement use actually experienced a nonsignificant increased risk of pancreatic cancer (relative risk = 1.60, 95 percent CI: 0.92, 2.77), a result similar in direction to the relative risk for current or past multivitamin users in our cohorts.
The reasons for the different apparent effect for dietary folate compared with supplemental folate observed in our cohorts as well as in the Finnish ATBC cohort are unclear. Supplemental folate is substantially more bioavailable than folate from food sources and therefore would be expected to offer greater potency. Within our cohorts, total folate and dietary folate assessed by questionnaire were correlated similarly with plasma folate levels (r = 0.63 for total folate; r = 0.61 for folate excluding supplements) (47) . This suggests that another dietary item that is correlated with dietary folate may have accounted for the suggestion of an inverse association between folate from food sources and pancreatic cancer risk. Alternatively, if the latency between developing and detecting a pancreatic cancer exceeded the follow-up period of this study, then the baseline folate assessment may misclassify the exposure temporally. Moreover, if dietary folate consumption patterns are stable over time, then food folate levels may represent folate exposure in the distant past that are more relevant to tumorigenesis than is recent exposure from multivitamin supplements. Finally, given the modestly increased risk observed with multivitamin supplement use, some component of multivitamin supplements that increases risk for pancreatic cancer may counterbalance an inverse association with total folate consumption.
The strengths of this study include its prospective design; validation of the relation between the questionnaire's measurement of folate intake and serum concentrations with a biochemical marker; detailed data on many potential confounders; high follow-up response rate, and data from two completely separate, large cohorts. The prospective design precluded recall bias and the need for next-of-kin respondents. We cannot exclude measurement error as an explanation for the lack of a significant association within either cohort in this study. Misclassification of folate intake as measured by the food frequency questionnaire may have attenuated the results to some degree; however, this is an unlikely explanation for the lack of any association over extreme levels of intake, since it is improbable that participants were misclassified from one extreme category to the other. Moreover, other analyses in these same cohorts have reported significant inverse associations between total folate intake and breast (44) and colon (16, 33, 48) cancers.
We cannot exclude that these findings may not be generalizable to populations of smokers or to those who are relatively folate deficient, such as the Finnish ATBC cohort. Cigarette smoking is associated with low folate status, interferes with methyl metabolism, and may modify any effect of folate intake on pancreatic cancer. In contrast, the majority of participants in the cohorts of this study were either never or former smokers. Furthermore, the distribution of alcohol consumption in this study's cohorts limited our ability to examine the influence of folate intake at high levels of alcohol consumption.
In summary, we observed no clear relation between folate intake and the risk of pancreatic cancer in two large prospective cohort studies. Further studies may reveal whether folate from food sources or some factor associated with food folate intake decreases the risk of pancreatic cancer. Although we cannot exclude the possibility that very low folate intake increases the risk of pancreatic cancer, among relatively folate-replete women and men in the United States, greater folate intake is unlikely to substantially influence the risk of pancreatic cancer.
